The Biomedical Research Foundation of the Academy of Athens (BRFAA) is set to launch in a couple of months a prequalification tender for the development of a laboratory project in Athens, Greece under the Public-Private Partnership (PPP) investment mode. 

The project involves the construction, acquisition of equipment and facility management of a new building in Athens for the provision of specialized services in the field of personalized medicine. The new facilities will house a state-of-the-art laboratory that meets high-tech specifications, in area totalling 20,000 m². The project also includes the renovation of the Loverdeion building, in order to create a unit for clinical trials of generic drugs. 

In April 2018, the  European Bank for Reconstruction and Development (EBRD) has signed an agreement with BRFAA to support the development of the project under the Bank's Infrastructure Project Preparation Facility (IPPF). EBRD covers the cost of technical assistance in the organization of this PPP project as well as the cost of preparing tenders for private investors.